

浏览全部资源
扫码关注微信
1.河南中医药大学,郑州 450046
2.呼吸疾病中医药防治省部共建协同创新中心,郑州 450046
3.苏州大学,江苏 苏州 215000
Received:21 April 2024,
Accepted:21 June 2024,
Published Online:19 June 2024,
Published:05 March 2025
移动端阅览
张允惠,刘艳丽,许琼明等.地榆皂苷Ⅰ在正常和急性肾损伤大鼠体内的药代动力学分析[J].中国实验方剂学杂志,2025,31(05):203-210.
ZHANG Yunhui,LIU Yanli,XU Qiongming,et al.Pharmacokinetic Analysis of Ziyuglycoside Ⅰ in Normal and Acute Kidney Injury Rats[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(05):203-210.
张允惠,刘艳丽,许琼明等.地榆皂苷Ⅰ在正常和急性肾损伤大鼠体内的药代动力学分析[J].中国实验方剂学杂志,2025,31(05):203-210. DOI: 10.13422/j.cnki.syfjx.20250163.
ZHANG Yunhui,LIU Yanli,XU Qiongming,et al.Pharmacokinetic Analysis of Ziyuglycoside Ⅰ in Normal and Acute Kidney Injury Rats[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(05):203-210. DOI: 10.13422/j.cnki.syfjx.20250163.
目的
2
基于超高效液相色谱-四极杆-静电场轨道阱-线性离子阱质谱法(UPLC-Orbitrap Fusion Lumos Tribrid-MS),测定口服给药后不同时间点地榆皂苷Ⅰ的血药浓度,对比分析其在正常大鼠与急性肾损伤大鼠体内的药代动力学特征。
方法
2
将48只雄性SD大鼠随机分为正常组和模型组,模型组腹腔注射顺铂(10 mg·kg
-1
)建立急性肾损伤模型,正常组给予等体积生理盐水。造模成功后,正常组及模型组大鼠随机分为正常低、中、高剂量组(2.5、5、7.5 mg·kg
-1
)和模型低、中、高剂量组(2.5、5、7.5 mg·kg
-1
),每组6只,分别灌胃相应剂量的地榆皂苷Ⅰ后收集不同时间点的血浆,采用UPLC-Orbitrap Fusion Lumos Tribrid-MS测定大鼠血浆中地榆皂苷Ⅰ的质量浓度,绘制药-时曲线,利用Kinetica 5.1软件计算药代动力学参数,以SPSS 22.0进行独立样本
t
检验比较不同给药组间药代动力学参数的差异。
结果
2
药代动力学结果显示,灌胃不同剂量的地榆皂苷Ⅰ后,其浓度均表现为先增大后减小,且均在0.5 h左右达到最大血药浓度;正常大鼠和模型大鼠药时曲线下面积(AUC
0-
t
)、平均滞留时间(MRT
0-
t
)随给药剂量增加而增多,清除率(CL)随给药剂量增加而减少。与正常组比较,不同给药剂量下模型组大鼠的AUC
0-
t
均显著增加(
P
<
0.01)、达峰浓度(
C
max
)均升高、CL均降低,表明动物的生理状态会影响地榆皂苷Ⅰ在体内的吸收与消除。
结论
2
地榆皂苷Ⅰ在正常大鼠体内和急性肾损伤模型大鼠体内药代动力学特征存在较大差异,可能为病理状态下体内环境变化,进而导致吸收和代谢过程发生变化。
Objective
2
Based on ultra-high performance liquid chromatography-quadrupole-electrostatic field orbital trap-linear ion-trap mass spectrometry(UPLC-Orbitrap Fusion Lumos Tribrid-MS), the plasma concentration of ziyuglycoside Ⅰ was determined at different time points after oral administration, and its pharmacokinetic characteristics in normal rats and rats with acute kidney injury were compared.
Methods
2
Rats were randomly divided into normal group and model group, the model group received intraperitoneal cisplatin(10 mg·kg
-1
) to establish the acute kidney injury model, the normal group was given the same volume of saline. After successful modeling, rats in the normal and model groups were randomly divided into the normal low, medium and high dose groups(2.5, 5, 7.5 mg·kg
-1
) and the model low, medium and high dose groups(2.5, 5, 7.5 mg·kg
-1
), 6 rats in each group, and the plasma was collected at different time points after receiving the corresponding dose of ziyuglycoside Ⅰ. Then, the concentration of ziyuglycoside Ⅰ in rat plasma was determined by UPLC-Orbitrap Fusion Lumos Tribrid-MS, and the drug-time curve was poltted. The pharmacokinetic parameters were calculated by Kinetica 5.1 software, and the differences in pharmacokinetic parameters between different administration groups were compared by independent sample
t
-test with SPSS 22.0.
Results
2
The pharmacokinetic results showed that after receiving the different doses of ziyuglycoside Ⅰ, its concentration increased first and then decreased, and all of them reached the maximum plasma concentration at about 0.5 h. The area under the curve(AUC
0-
t
) and mean retention time(MRT
0-
t
) of normal and model rats increased with the increased dose, and the clearance(CL) decreased with the increasing dose. Compared with the normal group, the AUC
0-
t
was significantly increased(
P
<
0.01), peak concentration(
C
max
) and CL decreased in mo
del rats at different doses, indicating that the physiological state of the rats could affect the absorption and elimination of ziyuglycoside Ⅰ
in vivo
.
Conclusion
2
The pharmacokinetic characteristics of ziyuglycoside Ⅰ are quite different in normal rats and acute kidney injury model rats, which may be due to the change of the body environment in the pathological state, then lead to changes in absorption and metabolic processes.
石柳柳 , 雷佳琦 , 付宇甜 , 等 . 槲皮素对脂多糖诱导小鼠急性肾损伤的保护作用及其机制研究 [J]. 湖北医药学院学报 , 2022 , 41 ( 6 ): 561 - 564,573,665 .
SHI L L , LEI J Q , FU Y T , et al . Protective effects and mechanism of quercetin on lipopolysaccharide-induced acute kidney injury in LPS [J]. J Hubei Univ Med , 2022 , 41 ( 6 ): 561 - 564,573,665 .
樊晓烨 . 瑞香素对急性肾损伤的保护作用及机制研究 [D]. 长春 : 吉林大学 , 2019 .
FAN X Y . The protective effects and mechanisms of daphnetin on acute kidney injury [D]. Changchun : Jilin University , 2019 .
丰姝姝 , 高旭杰 , 张珂 , 等 . 山楂叶提取物对庆大霉素诱导大鼠急性肾损伤的影响及机制研究 [J]. 石河子大学学报:自然科学版 , 2023 , 41 ( 2 ): 258 - 264 .
FENG S S , GAO X J , ZHANG K , et al . Study on the effects and mechanism of Hawthorn leaf extract on gentamicin-induced acute kidney injury in rats [J]. J Shihezi Univ:Nat Sci , 2023 , 41 ( 2 ): 258 - 264 .
JIA H M , JIANG Y J , ZHENG X , et al . The attributable mortality of sepsis for acute kidney injury:A propensity-matched analysis based on multicenter prospective cohort study [J]. Ren Fail , 2023 , 45 ( 1 ): 2162415 .
邬金鸣 , 孙海霞 , 王嘉阳 , 等 . 国内外急性肾损伤预测研究进展 [J]. 中华医学图书情报杂志 , 2021 , 30 ( 6 ): 17 - 28 .
WU J M , SUN H X , WANG J Y , et al . Advances in foreign and domestic prediction of acute kidney injury [J]. Chin J Med Libr Inf Sci , 2021 , 30 ( 6 ): 17 - 28 .
杨昊若 , 于大君 , 张昱 , 等 . 基于Keap1/Nrf2/ARE通路探讨槲皮素对LPS诱导的急性肾损伤大鼠铁死亡影响 [J]. 中国实验方剂学杂志 , 2024 , doi: 10.13422/j.cnki.syfjx.20240219 http://dx.doi.org/10.13422/j.cnki.syfjx.20240219 .
YANG H R , YU D J , ZHANG Y , et al . Quercetin attenuates ferroptosis against LPS-induced acute kidney injury rats via modulating Keap1/Nrf2/ARE pathway [J]. Chin J Exp Tradit Med Form , 2024 , doi: 10.13422/j.cnki.syfjx.20240219 http://dx.doi.org/10.13422/j.cnki.syfjx.20240219 .
胡佳丽 , 曹卉 , 雷茹 , 等 . 甘草素对急性肾损伤小鼠的保护机制研究 [J]. 局解手术学杂志 , 2023 , 32 ( 5 ): 389 - 393 .
HU J L , CAO H , LEI R , et al . Protective mechanism of liquiritigenin on acute kidney injury in mice [J]. J Reg Anat Oper Sur , 2023 , 32 ( 5 ): 389 - 393 .
徐大鹏 , 叶放 . 国医大师周仲瑛基于复合病机辨治慢性肾病 [J]. 中医学报 , 2023 , 38 ( 3 ): 572 - 577 .
XU D P , YE F . TCM master ZHOU Zhongying's experience in treating CKD based on compound pathogenesis [J]. China J Chin Med , 2023 , 38 ( 3 ): 572 - 577 .
倪天宇 , 张水利 , 俞冰 , 等 . 经典名方中地榆的本草考证 [J]. 中国实验方剂学杂志 , 2023 , 29 ( 5 ): 58 - 67 .
NI T Y , ZHANG S L , YU B , et al . Herbal textual research on Sanguisorbae Radix in famous classical formulas [J]. Chin J Exp Tradit Med Form , 2023 , 29 ( 5 ): 58 - 67 .
梁富庭 , 侯中宁 . 消化内镜配合地榆止血汤治疗高危急性非静脉曲张性上消化道出血临床观察 [J]. 实用中医药杂志 , 2022 , 38 ( 5 ): 765 - 767 .
LIANG F T , HOU Z N , et al . Clinical observation of digestive endoscopy combined with Diyu Zhixue decoction in the treatment of high risk acute non-variceal upper gastrointestinal bleeding [J]. J Prac Tradit Chin Med , 2022 , 38 ( 5 ): 765 - 767 .
ZHAO W , ZENG X , MENG F , et al . Structural characterization and in vitro - in vivo evaluation of effect of a polysaccharide from Sanguisorba officinalis on acute kidney injury [J]. Food Funct , 2019 , 10 ( 11 ): 7142 - 7151 .
国家药典委员会 . 中华人民共和国药典:一部 [J]. 北京 : 中国医药科技出版社 , 2020 : 130 .
Chinese Pharmacopoeia Commission . Pharmacopoeia of the People's Republic of China:Volume 1 [J]. Beijing : China Pharmaceutical Science and Technology Press , 2020 : 130 .
范奎 , 代良敏 , 熊永爱 , 等 . HPLC-ELSD法测定地榆总皂苷中地榆皂苷-Ⅰ和地榆皂苷-Ⅱ的含量 [J]. 中华中医药杂志 , 2017 , 32 ( 6 ): 2639 - 2642 .
FAN K , DAI L M , XIONG Y A , et al . Determination of the content of ziyuglycoside-Ⅰ and ziyuglycoside-Ⅱ in burnet total saponins by HPLC-ELSD [J]. Chin J Tradit Chin Med Pharm , 2017 , 32 ( 6 ): 2639 - 2642 .
秦肖菲 , 陈永新 . 地榆皂苷抗肿瘤机制及药物递送研究进展 [J]. 中国药剂学杂志 , 2020 , 18 ( 3 ): 180 - 186 .
QIN X F , CHEN Y X , et al . Research progress in anti-tumor mechanism and drug delivery system of ziyuglycoside [J]. Chin J Pharm , 2020 , 18 ( 3 ): 180 - 186 .
陈雪琴 . 地榆皂苷Ⅱ诱导粒细胞的增殖与分化治疗白细胞减少症的作用及机制研究 [D]. 南昌 : 江西科技师范大学 , 2023 .
CHEN X Q . Study on the effect and mechanism of Sanguisorba officinalis saponin Ⅱ inducing granulocyte proliferation and differentiation in the treatment of leukopenia [D]. Nanchang : Jiangxi Science and Technology Normal University , 2023 .
苏亮 , 杨德斌 . HPLC法测定地榆升白胶囊和不同产地地榆中地榆皂苷Ⅰ含量 [J]. 海峡药学 , 2022 , 34 ( 7 ): 62 - 65 .
SU L , YANG D B . Determination of ziyuglycoside Ⅰ in Diyu Shengbai capsule and Sanguisorba officinalis L.from different origins by HPLC [J]. Strait Pharm J , 2022 , 34 ( 7 ): 62 - 65 .
代雨贝 . 中药地榆化学成分及其体内代谢规律研究 [D]. 泸州 : 西南医科大学 , 2022 .
DAI Y B . Characterization of chemical constitutes and metabolites in vivo of Sanguisorba officinalis L .[D]. Luzhou : Southwest Medical University , 2022 .
罗静 , 冯伟勋 , 余泽兵 , 等 . 地榆皂苷Ⅱ对MFC胃癌荷瘤小鼠的抗肿瘤作用及机制 [J]. 时珍国医国药 , 2022 , 33 ( 4 ): 774 - 777 .
LUO J , FENG W X , YU Z B , et al . Anti-tumor effect and mechanism of ziyuglycoside Ⅱ on MFC gastric cancer tumor-bearing mice [J]. Lishizhen Med Mater Med Res , 2022 , 33 ( 4 ): 774 - 777 .
CHEN J F , TAN L , JU F , et al . Phenolic glycosides from Sanguisorba officinalis and their anti-inflammatory effects [J]. Nat Prod Res , 2022 , 36 ( 8 ): 2097 - 2104 .
王宝丽 , 邹迪新 , 程钱 , 等 . 京大戟化学成分及药理作用研究概述 [J]. 环球中医药 , 2016 , 9 ( 7 ): 896 - 900 .
WANG B L , ZOU D X , CHENG Q , et al . Research summary on chemistry composition and pharmacological action of Euphorbia pekinensis [J]. Glob Tradit Chin Med , 2016 , 9 ( 7 ): 896 - 900 .
包代琴 , 刘奕言 , 张紫森 , 等 . 地榆皂苷Ⅰ对脓毒症大鼠急性肺损伤的保护作用及机制研究 [J]. 中国药房 , 2023 , 34 ( 5 ): 537 - 543 .
BAO D Q , LIU Y Y , ZHANG Z X , et al . Study on protective effects and mechanism of ziyuglycoside Ⅰ on acute lung injury in sepsis rats [J]. China Pharm , 2023 , 34 ( 5 ): 537 - 543 .
王哲纬 , 周安远 , 王勇麟 , 等 . 地榆皂苷Ⅰ对大鼠膝骨关节炎的作用机制研究 [J]. 中国临床新医学 , 2024 , 17 ( 6 ): 639 - 644 .
WANG Z W , ZHOU A Y , WANG Y L , et al . A study on mechanism of action of ziyuglycoside Ⅰ on knee osteoarthritis in rats [J]. Chin J New Clin Med , 2024 , 17 ( 6 ): 639 - 644 .
张佳莉 , 张岩 . 急性肾损伤动物模型构建方法与研究现状 [J]. 中国实验动物学报 , 2022 , 30 ( 7 ): 955 - 965 .
ZHANG J L , ZHANG Y . Research approaches and status of animal models for acute kidney injury [J]. Acta Lab Anim Sci Sin , 2022 , 30 ( 7 ): 955 - 965 .
胡迪 , 刘静 , 赵梦丹 , 等 . 急性肾损伤动物模型的研究进展 [J]. 吉林医药学院学报 , 2022 , 43 ( 3 ): 215 - 218 .
HU D , LIU J , ZHAO M D , et al . Research progress of animal models of acute kidney injury [J]. J Jilin Med Univ , 2022 , 43 ( 3 ): 215 - 218 .
郭锦洲 . 改善全球肾脏病预后组织(KDIGO)临床实践指南:急性肾损伤 [J]. 肾脏病与透析肾移植杂志 , 2013 , 22 ( 1 ): 57 - 60 .
GUO J Z . Clinical practice guidelines of Kidney Disease Improving Global Outcomes(KDIGO):Acute kidney injury [J]. Chin J Nephrol Dial Transpl , 2013 , 22 ( 1 ): 57 - 60 .
廖永翠 , 马广强 , 杨中杰 . 地榆皂苷Ⅰ升高白细胞的药效学初步研究 [J]. 深圳中西医结合杂志 , 2021 , 31 ( 8 ): 4 - 6 .
LIAO Y C , MA G Q , YANG Z J . Preliminary study on the pharmacodynamics of Sanguisorba officinalis saponin saponin Ⅰ in increasing white blood cells [J]. Shenzhen J Int Tradit Chin and West Med , 2021 , 31 ( 8 ): 4 - 6 .
代良敏 , 熊永爱 , 杨桂燕 , 等 . 地榆皂苷类成分对环磷酰胺致小鼠骨髓抑制的保护作用研究 [J]. 天然产物研究与开发 , 2016 , 28 ( 6 ): 852 - 859 .
DAI L M , XIONG Y A , YANG J Y , et al . Protective effect of tannins from Sanguisorba officinalis on cyclophosphamide-induced myelosuppression in mice [J]. Nat Prod Res Dev , 2016 , 28 ( 6 ): 852 - 859 .
孙晓怡 , 姜玉勤 , 陆迅 . 铂类抗肿瘤药物相关的急性肾损伤机制研究进展 [J]. 医学研究生学报 , 2021 , 34 ( 2 ): 194 - 199 .
SUN X Y , JIANG Y Q , LU X . Research progress on the mechanism of acute kidney injury caused by platinum based antitumor drugs [J]. J Med Postgraduates , 2021 , 34 ( 2 ): 194 - 199 .
YAMAMOTO Y , HOTTA Y , TOMITA N , et al . Changes in zinc and manganese concentrations in cisplatin-induced acute kidney injury [J]. Biochem Biophys Rep , 2023 , 33 : 101422 .
陈晓媚 , 马圆媛 , 聂静 , 等 . 急性肾损伤向慢性肾脏病转化中肾小管上皮细胞损伤修复机制的研究进展 [J]. 首都医科大学学报 , 2022 , 43 ( 5 ): 720 - 727 .
CHEN X M , MA Y Y , NIE J , et al . Progress on the injury and repair mechanism of renal tubular epithelial cells in the transition of acute kidney injury to chronic kidney disease [J]. J Cap Med Univ , 2022 , 43 ( 5 ): 720 - 727 .
蔡荣珊 . 地榆皂苷Ⅰ-金纳米粒的构建及其对造血干细胞自噬的影响研究 [D]. 遵义 : 遵义医科大学 , 2023 .
CAI R S . The Construction of ziyuglycoside Ⅰ-AuNPs and its effects on autophagy in hematopoietic stem cells [D]. Zunyi : Zunyi Medical University , 2022 .
代良敏 , 代良萍 , 陈永钧 , 等 . 基于Box-Behnken实验优化地榆皂苷元固体脂质纳米粒的制备 [J]. 时珍国医国药 , 2023 , 34 ( 9 ): 2117 - 2120 .
DAI L M , DAI L P , CHEN Y J , et al . Preparation and optimization of burnet sapogenin loading solid lipid nanoparticle by using Box-Behnken design [J]. Lishizhen Med Mater Med Res , 2023 , 34 ( 9 ): 2117 - 2120 .
吴冠中 , 曹军 , 吴云腾 , 等 . 中医药抗肿瘤治疗致骨髓抑制的研究进展 [J]. 山东中医杂志 , 2023 , 42 ( 12 ): 1347 - 1353 .
WU G Z , CAO J , WU Y T , et al . Research progress on treating myelosuppression caused by anti-tumor therapy with traditional Chinese medicine [J]. Shandong J Tradit Chin Med , 2023 , 42 ( 12 ): 1347 - 1353 .
邹娅 . 地榆皂苷自乳化递药系统的构建及评价 [D]. 遵义 : 遵义医科大学 , 2019 .
ZOU Y . Construction and evaluation of self-emulsifying drug delivery system of saponins of Sanguisorba officinalis [D]. Zunyi : Zunyi Medical University , 2019 .
郝晶晶 , 郭瑛玉 , 胡海燕 , 等 . 金红片中活性成分在正常大鼠和浅表性胃炎大鼠体内的药代动力学研究 [J]. 药物分析杂志 , 2023 , 43 ( 9 ): 1565 - 1573 .
HAO J J , GUO Y Y , HU H Y , et al . Pharmacokinetics of active components in Jinhong tablets in normal and superficial gastritis rats [J]. Chin J Pharm Anal , 2023 , 43 ( 9 ): 1565 - 1573 .
刘莹 , 贾兰 , 张晓喻 , 等 . 大黄素配伍黄芩素在正常和2型糖尿病大鼠中药代动力学研究 [J]. 中国临床药理学杂志 , 2023 , 39 ( 19 ): 2834 - 2838 .
LIU Y , JIA L , ZHANG X Y , et al . Pharmacokinetics study of emodin combined with baicalein in normal and type 2 diabetic rats [J]. Chin J Clin Pharm , 2023 , 39 ( 19 ): 2834 - 2838 .
ANDERS H J , ANDRASSY J , LICHTNEKERT J . Regulators of necroinflammation in acute kidney injury [J]. Kidney Int , 2024 , 105 ( 1 ): 22 - 25 .
范旭 . Circ-0045861/miR-181d-5p及m6A修饰调控SIRT1在梗阻性肾损伤修复中的作用机制研究 [D]. 沈阳 : 中国医科大学 , 2021 .
FAN X . Circ-0045861/miR-181d-5p and m6A modification regulate therole of SIRT1 in the repair of obstructive renal injury [D]. Shenyang : China Medical University , 2021 .
杨诗宇 , 宋基正 , 杨山景 , 等 . 芦丁药理作用与新剂型的研究进展 [J]. 中国现代应用药学 , 2022 , 39 ( 10 ): 1360 - 1370 .
YANG S Y , SONG J Z , YANG S J , et al . Research progress on pharmacological action and new dosage forms of rutin [J]. Chin J Mod Appl Pharm , 2022 , 39 ( 10 ): 1360 - 1370 .
0
Views
137
下载量
1
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621